Abbott Laboratories to pay $385 million over baby formula contamination

Negative3 min readAI-generated summary

Report this article

Tell us what is wrong. We read every report.

Report this article
Abbott Laboratories to pay $385 million over baby formula contamination
Health

Aol

Abbott Laboratories agreed to pay nearly $385 million to resolve a civil False Claims Act case with the Justice Department and several states after Cronobacter bacterial contamination at its Sturgis, Michigan powdered infant formula plant. Federal prosecutors had sought felony charges but senior Justice Department leaders would not allow the criminal case to proceed and the department closed that probe. The Justice Department alleged unsanitary conditions, failure to fix roof leaks, avoidance of testing, and nondisclosure of micro contamination to the Food and Drug Administration in 2019 and 2022; Abbott said the settlement is not an admission of fault and government tests of unopened recalled products were negative.

Abbott will pay nearly $385 million to settle contamination claims

Context

In 2022 Abbott recalled Similac and other powdered formula after infant illnesses linked to products from its Sturgis plant. Federal prosecutors investigated and later a criminal probe was closed, leading to a civil settlement. Congress…

The full analysis

19 dimensions on this story — world impact, market read, and what happens next.

  • Full ContextLocked
  • Affected SectorsLocked
  • Stock ImpactLocked
  • Economic IndicatorLocked
  • Investor RelevanceLocked
  • Professional RelevanceLocked
  • Watch PointsLocked
  • Probability of ChangeLocked
  • Debate PointsLocked
  • Historical ParallelLocked
  • Follow-up QuestionsLocked
  • Pros & ConsLocked
Read free — no credit card